Free Shipping Worldwide. Please expect up to 3-4 weeks shipping due to COVID supply chain delays for PDCare.


Here are some top research studies our products are developed upon.


Improvements in clinical signs of Parkinson’s disease using photobiomodulation: a prospective proof-of-concept study.

More Research Supporting Light Therapy

"PBM was shown to be a safe and potentially effective treatment. Improvements were maintained for as long as treatment continued, for up to one year in a neurodegenerative disease where decline is typically expected." - BMC Neurology

How does light therapy offer neurological protection in Parkinson's disease? - NCBI

Treating the microbiome to affect changes in Parkinson’s patients. - Science Direct

Michael R Hamblin, 19 May 2017, Mechanisms and Applications of the Anti-inflammatory effects of Photobiomodulation - AIMS Biophysics Journal

Strong evidence identifying inhibition of nerve function as a mechanism for the clinical application of PBM in pain and anesthesia. - Mary Ann Liebert, Inc

Remote Photobiomodulation Treatment for the Clinical Signs of Parkinson's
Disease: A Case Series Conducted During Lockdown - Pub Med

Why Light Therapy?

Light therapy is the non-thermal delivery of waves of light energy with a therapeutic benefit. SYMBYX’s medical-grade lasers are easy to use at home and ARTG/CE listed for reduction in many symptoms.

View More